EBIT at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s EBIT?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported EBIT of -$43.78M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s EBIT decreased by 15.8% year-over-year, from -$37.8M to -$43.78M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s EBIT has grown at a 16.7% compound annual growth rate (CAGR), from -$82.69M to -$153.29M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.